Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC NS1643 | 448895-37-2 | 99.04% | 380.24 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY16916

Encompass_Preferred

NS1643 is a partial agonist of human ether-a-go-go-related gene (hERG) K+ channels with an EC50 of 10.5 μM. It inhibits the growth of breast cancer tumors in TNBC mouse models and also inhibits cell migration and invasion of breast cancer cells.

  • Partial agonist of hERG K+ channels (EC50 of 10.5 μM)
  • Inhibits breast cancer tumor growth in TNBC mouse models
  • Inhibits cell migration and invasion of breast cancer cells
  • Dose- and voltage-dependently increases hERG current in oocytes
  • Slows the rate of hERG inactivation and reduces hERG channel rectification
  • Decreases Vimentin, N-cadherin, and CD44 levels, and increases E-cadherin in breast cancer cell lines (MDA-MB-231, SKBR3, and MCF7)
  • Inhibits breast tumor metastasis in NSG mice with human-derived TNBC tumor xenografts

Catalog No. 50-003-95300


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.